Clinical Trial Update: A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial evaluated pharmacokinetics and the neoadjuvant activity of combining anastrozole with the Src inhibitor saracatinib (AZD0530) in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Saracatinib (saracatinib)

Snippet

Sponsor: Joyce Marie Slingerland, MD | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-31